Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of ADVATE rAHF-PFM in Severe Hemophilia A
NCT00289536Phase 4Completed
- Sponsor
- Takeda
- Start
- Feb 2006
- Primary completion
- Apr 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of octocog alfa in hemophilia A, sponsored by Takeda. Started Feb 2006; status: completed.
02
Drugs
octocog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT00289536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00289536.